Literature DB >> 7672043

The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Provincial Group for the Study of Chronic Liver Disease.

G Corrao1, A R Lepore, P Torchio, M Valenti, G Galatola, A D'Amicis, S Aricó, F di Orio.   

Abstract

In order to assess the interaction between alcohol intake, tobacco smoking and coffee consumption in determining the risk of liver cirrhosis we carried out a hospital-based case-control study involving 115 patients at their first diagnosis of cirrhosis and 167 control patients consecutively enrolled in the General Hospitals of the Province of L'Aquila (Central Italy). The mean life-time daily alcohol intake (as g ethanol consumed daily) was measured by direct patient interviews, whose reproducibility was > 0.80 and similar for cases and controls, as checked by interviewing the relatives of a sample of 50 cases and 73 controls. During the same patient's interview we also measured the mean consumption of coffee (daily number of cups of filtered coffee) and tobacco (life-time daily number of cigarettes smoked). A dose-effect relationship on the risk of cirrhosis was present both for alcohol intake--for which the risk was significantly increased above 100 g of daily intake--and for cigarette consumption. The latter did not however improve the goodness-of-fit of a logistic regression model including alcohol intake as covariate. By contrast, coffee consumption had a protective effect on the risk of cirrhosis and significantly improved the goodness-of-fit of such a model. Abstaining from coffee consumption determined both a significantly increased risk of cirrhosis, even for daily alcohol intake below 100 g, and a multiplicative effect with alcohol intake on this risk. In patients drinking > or = 101 g ethanol daily the relative risk increased from 5.5 (95% confidence interval: 1.4-22.0) for coffee consumers to 10.8 (95% confidence interval: 1.3-58.1) for coffee abstainers.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7672043     DOI: 10.1007/bf01719277

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  29 in total

1.  The estimation of synergy or antagonism.

Authors:  K J Rothman
Journal:  Am J Epidemiol       Date:  1976-05       Impact factor: 4.897

Review 2.  Epidemiology of alcoholic liver disease.

Authors:  B F Grant; M C Dufour; T C Harford
Journal:  Semin Liver Dis       Date:  1988-02       Impact factor: 6.115

3.  Unexpected effects of coffee consumption on liver enzymes.

Authors:  E Casiglia; P Spolaore; G Ginocchio; G B Ambrosio
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

4.  Fatty liver, alcoholic hepatitis and cirrhosis produced by alcohol in primates.

Authors:  E Rubin; C S Lieber
Journal:  N Engl J Med       Date:  1974-01-17       Impact factor: 91.245

5.  Reliability of assessment of alcohol intake based on personal interviews in a liver clinic.

Authors:  H Orrego; J E Blake; L M Blendis; B M Kapur; Y Israel
Journal:  Lancet       Date:  1979 Dec 22-29       Impact factor: 79.321

6.  Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis.

Authors:  T I Sørensen; M Orholm; K D Bentsen; G Høybye; K Eghøje; P Christoffersen
Journal:  Lancet       Date:  1984-08-04       Impact factor: 79.321

7.  Influence of alcohol and caffeine consumption on caffeine elimination.

Authors:  J George; T Murphy; R Roberts; W G Cooksley; J W Halliday; L W Powell
Journal:  Clin Exp Pharmacol Physiol       Date:  1986-10       Impact factor: 2.557

8.  Ascitic cirrhosis in relation to alcohol consumption.

Authors:  G Pequignot; A J Tuyns; J L Berta
Journal:  Int J Epidemiol       Date:  1978-06       Impact factor: 7.196

9.  Sequential production of fatty liver, hepatitis, and cirrhosis in sub-human primates fed ethanol with adequate diets.

Authors:  C S Lieber; L DeCarli; E Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

10.  An epidemiologic study of effects of alcohol in the liver in hepatitis B surface antigen carriers.

Authors:  H Nomura; S Kashiwagi; J Hayashi; W Kajiyama; H Ikematsu; A Noguchi; S Tani; M Goto
Journal:  Am J Epidemiol       Date:  1988-08       Impact factor: 4.897

View more
  27 in total

Review 1.  Binge drinking: Burden of liver disease and beyond.

Authors:  Susana Llerena; María Teresa Arias-Loste; Angela Puente; Joaquín Cabezas; Javier Crespo; Emilio Fábrega
Journal:  World J Hepatol       Date:  2015-11-28

Review 2.  Adenosine receptors in wound healing, fibrosis and angiogenesis.

Authors:  Igor Feoktistov; Italo Biaggioni; Bruce N Cronstein
Journal:  Handb Exp Pharmacol       Date:  2009

3.  Alcohol Consumption and Risk of Liver Cirrhosis: A Systematic Review and Meta-Analysis.

Authors:  Michael Roerecke; Afshin Vafaei; Omer S M Hasan; Bethany R Chrystoja; Marcus Cruz; Roy Lee; Manuela G Neuman; Jürgen Rehm
Journal:  Am J Gastroenterol       Date:  2019-10       Impact factor: 10.864

Review 4.  Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?

Authors:  Moon-Sun Kim; Madeleine Ong; Xianqin Qu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

5.  Clearing the smoke in chronic liver diseases.

Authors:  Claudia O Zein
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

6.  Coffee prevents CCl(4)-induced liver cirrhosis in the rat.

Authors:  Mario G Moreno; Enrique Chávez; Liseth R Aldaba-Muruato; José Segovia; Paula Vergara; Víctor Tsutsumi; Mineko Shibayama; Yadira Rivera-Espinoza; Pablo Muriel
Journal:  Hepatol Int       Date:  2011-01-25       Impact factor: 6.047

7.  Smoking is not associated with nonalcoholic fatty liver disease.

Authors:  Norberto-C Chavez-Tapia; Javier Lizardi-Cervera; Oliver Perez-Bautista; Martha H Ramos-Ostos; Misael Uribe
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

8.  Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma.

Authors:  Valter Donadon; Massimiliano Balbi; Francesca Valent; Angelo Avogaro
Journal:  World J Gastroenterol       Date:  2010-06-28       Impact factor: 5.742

Review 9.  Coffee and Liver Disease.

Authors:  Manav Wadhawan; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2016-02-27

10.  Alcohol and HCV chronic infection are risk cofactors of type 2 diabetes mellitus for hepatocellular carcinoma in Italy.

Authors:  Massimiliano Balbi; Valter Donadon; Michela Ghersetti; Silvia Grazioli; Giovanni Della Valentina; Rita Gardenal; Maria Dal Mas; Pietro Casarin; Giorgio Zanette; Cesare Miranda; Paolo Cimarosti
Journal:  Int J Environ Res Public Health       Date:  2010-03-29       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.